TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Onkologia AB
Closing information (x1000 SEK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
1,441
|
1,217 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
1,290
|
1,110 | |
| EBITDA |
1,224
|
1,110 | |
| Total assets |
3,899
|
3,190 | |
| Current assets |
1,495
|
2,100 | |
| Current liabilities |
164
|
103 | |
| Equity capital |
3,735
|
3,087 | |
| - share capital |
50
|
50 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
95.8%
|
96.8% | |
| Turnover per employee |
1,441
|
1,217 | |
| Profit as a percentage of turnover |
89.5%
|
91.2% | |
| Return on assets (ROA) |
33.1%
|
34.8% | |
| Current ratio |
911.6%
|
2038.8% | |
| Return on equity (ROE) |
34.5%
|
36.0% | |
| Change turnover |
224
|
50 | |
| Change turnover % |
2%
|
18%
|
4% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.